← Who reports today · Health Care
HCA Healthcare (HCA) earnings date & Q3 2026 results
Net income attributable to HCA Healthcare, Inc.
$1,579M
down 3.9% y/y
Revenues
$19,849M
up 3.6% y/y
Next report
~ Jan 26
not announced yet
The quarter in brief
Revenue increased 3.6% to $19.849 billion, while net income attributable to HCA Healthcare declined 3.9% to $1.579 billion. Diluted EPS increased 4.5% to $7.27.
Key growth driver: Revenue growth of +4% y/y — the report gives no segment split, so the driver is the whole business. · by the Q3 2026 report
All figures in $M.
| Line item | Amount and change |
|---|---|
| Revenues | $19,849 · +3.6% |
| Salaries and benefits | $8,581 · +2.6% |
| Supplies | $2,822 · +1.4% |
| Other operating expenses | $4,548 · +9.3% |
| Equity in earnings of affiliates | $20 · +25.0% |
| Depreciation and amortization | $954 · +7.3% |
| Interest expense | $607 · +8.2% |
| Losses (gains) on sales of facilities | $13 · vs −$2 |
| Income before income taxes | $2,370 · −2.0% · 11.9% margin |
| Provision for income taxes | $521 · +1.2% · 22.0% effective rate |
| Net income attributable to noncontrolling interests | $270 · +3.8% |
| Net income attributable to HCA Healthcare, Inc. | $1,579 · −3.9% · $7.27/sh · 8.0% margin |
Verdict: Revenue increased 3.6% to $19.849 billion, while net income attributable to HCA Healthcare declined 3.9% to $1.579 billion. Diluted EPS increased 4.5% to $7.27.
HCA expects full-year 2026 operating results in the upper half of its guidance ranges, including revenue of $77,000–$79,500 million and diluted EPS of $28.70–$30.50. Quarterly share repurchases totaled $2.970 billion for 7.230 million shares, and the declared quarterly dividend was $0.78 per share.
Source and notation
Source: HCA Healthcare earnings release, 8-K EX-99 of 10/27/2026 (SEC EDGAR).
Open as an image: HCA Healthcare (HCA), Q3 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0
Cite / embed this chart
Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).
Chart: “HCA Healthcare (HCA) Q3 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/hca. Licensed under CC BY 4.0.
<figure> <a href="https://whoreportstoday.com/t/hca"><img src="https://whoreportstoday.com/t/hca/img/hca-healthcare-earnings-sankey.png" alt="HCA Healthcare (HCA) Q3 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a> <figcaption>Source: <a href="https://whoreportstoday.com/t/hca">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption> </figure>
https://whoreportstoday.com/t/hca/img/hca-healthcare-earnings-sankey.png
<a href="https://whoreportstoday.com/t/hca">HCA Healthcare (HCA) Q3 2026 earnings chart (Who Reports Today)</a>
The image link always shows the latest report’s chart and will update with the next quarter. To keep this exact chart in your article, save the PNG and upload it yourself — the license allows that. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.
- Same-facility equivalent admissions increased 3.0%, and revenue per equivalent admission increased 0.6%.
- The shift toward uninsured patients reduced quarterly pretax income by approximately $400 million, according to the company.
- Other operating expenses increased to $4,548 million from $4,161 million, while interest expense increased to $607 million from $561 million.
- Facility sales generated a $13 million gain, compared with a $2 million loss a year earlier.
- Diluted weighted-average shares declined to 217.212 million from 236.181 million, while net income attributable to HCA Healthcare declined to $1,579 million from $1,643 million.
What distorts the picture in this report and what to watch beyond the headlines.
Who runs the company now
- Samuel N. HazenChief Executive Officer [1]
- Michael A. MarksExecutive Vice President and Chief Financial Officer [2]
As of 11/18/2026, per the company’s SEC filings: signatures on the latest report and leadership-change filings.
Positions and previous jobs: the company’s SEC filings. Spotted an error, or is this you and you’d like it corrected or removed? Contact us
Where they worked before
- HCA Healthcaresince 1995
- Chief Executive Officersince 2019
- Directorsince 2018
- President and Chief Operating Officer2016–2018
- Chief Operating Officer2015–2016
- President — Operations2011–2015
- President — Western Group2001–2011
- Chief Financial Officer — Western Group1995–2001
- Hospital, regional and division CFO positions
- Galen Health CareHospital, regional and division CFO positions
Source: SEC EDGAR: 10-K annual report, 2026-02-10 · as of 10/21/2026
- HCA Healthcaresince 2004
- Executive Vice President and Chief Financial Officersince 2024
- Senior Vice President — Finance2023–2024
- Vice President — Financial Operations Support2021–2022
- CFO of the National Group2008–2021
- CFO of the West Florida Division2004–2008
Source: SEC EDGAR: 10-K annual report, 2026-02-10 · as of 10/21/2026
How this is compiled
Who runs the company now comes from primary sources only: for US and Canadian companies, the CEO and CFO signatures on the latest SEC report, and a separate board chair from the proxy materials; for Russian and Kazakh issuers, the company website and its disclosures. We recheck weekly; if a name can’t be confirmed, or a leadership-change filing came out after the report, we don’t show it until it’s reviewed. Previous jobs are only what the company itself disclosed about its current leaders (the past five years of business experience in the annual report and proxy materials): employer, position and years, restated as facts, with no age, education or other personal details. If the company doesn’t disclose it, we don’t look elsewhere. Anything more than 400 days past its last check is hidden. These are public business facts from disclosures, shown to tell investors who runs the company (our legitimate interest); if this is you and you object, contact us via the link above and we’ll remove it.
Sources · 2
- SEC EDGAR: 10-Q 2026-10-29 · SEC EDGAR · 11/18/2026
- SEC EDGAR: 10-Q 2026-10-29 · SEC EDGAR · 11/18/2026
HCA Healthcare — It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. · Text: Wikipedia, CC BY-SA 4.0, abridged
Company reports
Company guidance
The company reaffirmed its outlook, no figures in the release.
Same quarter a year ago (ended December 31, 2025): revenue $19.5B, EPS (GAAP) $8.09
How we calculate
Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.
Guidance comes from the company's earnings release (Form 8-K filed Oct 27, 2026); every figure is checked against the release text.
HCA earnings history: past report dates
| Oct 27, 2026 Tue | 7:17 ambefore market open | Sep 30, 2026 | $19.8B+4% y/y | $7.27+4% y/y |
| Jul 14, 2026 Tue | 7:40 ambefore market open | Jun 30, 2026 | $20.2B+9% y/y | $7.62+12% y/y |
| Apr 24, 2026 Fri | 7:11 ambefore market open | Mar 31, 2026 | $19.1B+4% y/y | $7.15+11% y/y |
| Jan 27, 2026 Tue | 7:12 ambefore market open | Dec 31, 2025 | ≈$19.5B+7% y/y | ≈$8.09+43% y/y |
| Oct 24, 2025 Fri | 7:16 ambefore market open | Sep 30, 2025 | $19.2B+10% y/y | $6.96+43% y/y |
| Jul 25, 2025 Fri | 7:46 ambefore market open | Jun 30, 2025 | $18.6B+6% y/y | $6.83+24% y/y |
| Apr 25, 2025 Fri | 7:48 ambefore market open | Mar 31, 2025 | $18.3B+6% y/y | $6.45+9% y/y |
| Jan 24, 2025 Fri | 7:40 ambefore market open | Dec 31, 2024 | ≈$18.3B+6% y/y | ≈$5.66−4% y/y |
| Oct 25, 2024 Fri | 7:38 ambefore market open | Sep 30, 2024 | $17.5B+8% y/y | $4.88+25% y/y |
| Jul 23, 2024 Tue | 8:03 ambefore market open | Jun 30, 2024 | $17.5B+10% y/y | $5.53+29% y/y |
| Apr 26, 2024 Fri | 8:01 ambefore market open | Mar 31, 2024 | $17.3B+11% y/y | $5.93+22% y/y |
| Jan 30, 2024 Tue | 8:01 ambefore market open | Dec 31, 2023 | ≈$17.3B+12% y/y | ≈$5.92−18% y/y |
| Oct 24, 2023 Tue | 8:27 ambefore market open | Sep 30, 2023 | $16.2B+8% y/y | $3.91+0% y/y |
| Jul 27, 2023 Thu | 7:55 ambefore market open | Jun 30, 2023 | $15.9B+7% y/y | $4.29+10% y/y |
| Apr 21, 2023 Fri | 7:30 ambefore market open | Mar 31, 2023 | $15.6B+4% y/y | $4.85+17% y/y |
Show all 15 reports since 2023Show fewer
How we count
Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.
HCA Healthcare: 15-year financials
| 2025 | 75,600 | 6,784 | 7,692 | 679 |
| 2024 | 70,603 | 5,760 | 5,639 | 690 |
| 2023 | 64,968 | 5,242 | 4,687 | 661 |
| 2022 | 60,233 | 5,643 | 4,127 | 653 |
| 2021 | 58,752 | 6,956 | 5,382 | 624 |
| 2020 | 51,533 | 3,754 | 6,397 | 153 |
| 2019 | 51,336 | 3,505 | 3,444 | 550 |
| 2018 | 46,677 | 3,787 | 3,188 | 487 |
| 2017 | 43,614 | 2,216 | 2,411 | 0 |
| 2016 | 41,490 | 2,890 | 2,893 | — |
| 2015 | — | 2,129 | 2,359 | — |
| 2014 | 36,918 | 1,875 | 2,272 | 7 |
| 2013 | 34,182 | 1,556 | 1,737 | 16 |
| 2012 | 33,013 | 1,605 | 2,313 | 3,148 |
| 2011 | 29,682 | 2,465 | 2,254 | 31 |
$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*.
How we calculate
Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. The table starts in 2011; where the listed issuer changed (holding reorganization, redomicile), earlier years come from the predecessor’s filings.
HCA Healthcare: 15-year balance sheet
| Year | Assets | Equity | Debt | Cash | Current assets | Current liabilities |
|---|---|---|---|---|---|---|
| 2025 | 60,720 | −6,027 | 44,285 | 1,040 | 15,783 | 16,350 |
| 2024 | 59,513 | −2,499 | 43,031 | 1,933 | 16,414 | 15,177 |
| 2023 | 56,211 | −1,774 | 39,593 | 935 | 14,927 | 12,655 |
| 2022 | 52,438 | −2,767 | 38,084 | 908 | 13,643 | 9,902 |
| 2021 | 50,742 | −933 | 34,579 | 1,451 | 13,542 | 9,582 |
| 2020 | 47,490 | 572 | 31,004 | 1,793 | 12,333 | 8,704 |
| 2019 | 45,058 | −2,808 | 33,722 | 621 | 11,196 | 7,757 |
| 2018 | 39,207 | −4,950 | 32,821 | 502 | 10,213 | 7,569 |
| 2017 | 36,593 | −6,806 | 33,058 | 732 | 9,977 | 6,158 |
| 2016 | 33,758 | −7,302 | 31,376 | 646 | 9,086 | 5,834 |
| 2015 | 32,744 | −7,599 | 30,488 | 741 | 9,232 | 5,516 |
| 2014 | 30,980 | −7,894 | 29,426 | 566 | 8,930 | 5,480 |
| 2013 | 28,594 | −8,270 | 28,376 | 414 | 8,037 | 5,695 |
| 2012 | 28,075 | −9,660 | 28,930 | 705 | 7,763 | 6,172 |
| 2011 | 26,898 | −8,258 | 27,052 | 373 | 7,233 | 5,554 |
$ millions, at fiscal year-end*.
* Sources
How we calculate
Annual balance sheet figures. “—” means no data; zero appears only when a numeric zero is present. Metrics with fewer than two values are omitted. Annual amounts use the financial screener data, in the reporting currency. Equity is attributable to shareholders where available, otherwise total equity including noncontrolling interests. Debt and cash follow the stored figures: they may include leases and restricted cash. Snapshot updated: .
Cash flow
9 months ended 2026-09-30 · $M
| Line | This period | Year ago | Δ |
|---|---|---|---|
| Operating cash flowcash the business generated | 8,810 | 10,277 | −1,467 |
| · incl. D&A (non-cash add-back)depreciation & amortization | 2,828 | 2,612 | |
| · incl. stock-based comp (non-cash)share-based compensation | 304 | 301 | |
| Capexpurchases of property & equipment | −3,707 | −3,455 | −252 |
| Free cash flow ≈operating cash flow − capex | 5,103 | 6,822 | −1,719 |
| Investing activities, netcapex, acquisitions, securities | −4,755 | −3,671 | −1,084 |
| Financing activities, netdebt, buybacks, dividends | −4,183 | −7,551 | +3,368 |
| · incl. buybacksrepurchases of common stock | −6,605 | −7,509 | +904 |
| · incl. dividends paid | −519 | −517 | −2 |
| FX effect on cash | −4 | 9 | −13 |
| Net change in cash | −132 | −936 | +804 |
How to read the table
Cash flow is cumulative from the start of the fiscal year, rather than a single quarter. Lines marked ≈ are derived. Green Δ means more cash in (or less out) than a year ago. ≈ in Δ means a difference that rounds to zero at the displayed precision.
Shareholders’ equity at Sep 30, 2026: −$8.1B (−13% of total assets). Other S&P 500 companies with negative equity →
Corporate governance
2/2good
- Feb 2016HCA agreed to pay $215M to settle a class action by shareholders who bought in the 2011 IPO; the final approval hearing is set for April 11, 2016. sec.gov ↗
- May 2016Repurchase of 9.36M shares from KKR affiliates at $80.12 — the closing price minus 1% — under the general buyback program. sec.gov ↗
2 more facts and scoring
How the company treats minority shareholders: 2 — well, 0 — systematically poorly.
- Feb 2026Per the 2025 10-K: one class of shares; four $0.72 dividends in 2025 and 26.7M shares repurchased; the Frist group owns ~31%. sec.gov ↗
- Dec 2025Diluted share count fell 30.3% over 2020→2025 (XBRL 10-K). data.sec.gov ↗
Scoring: 2.0 −0.25 (criterion 9: shareholder suit over the 2011 IPO, $215M, approved April 2016 — more than 10 years old, half of −0.5) = 1.75 → 2.0
- Share classes
- Single class of common stock; the Frist family (~32%) nominates two directors under a shareholder agreement — no super-voting shares.
- Dilution
- Diluted share count 2020→2025 −30.3% thanks to buybacks (26.7M shares in 2025); SBC 0.5%.
- Disclosure
- 10-Ks and 10-Qs filed on time, audited US GAAP financials; no deduction.
- Dividends
- Quarterly dividend of $0.72 in 2025, $0.78 from 2026; the 2010/2012 special dividends came before/after the IPO and are more than 10 years old; no policy violations.
- Lawsuits & regulators
- IPO shareholder suit — $215M (2016, half weight); current cases are industry-wide (Medicare/DOJ), no deduction.
- Related parties
- Repurchase from KKR (former sponsor) in 2016 at the closing price minus 1%; a 2026 share exchange with Frisco (the Frists) reduced the share count by 72K — no deduction.
How the score works · checked as of Oct 2026
HCA Healthcare (HCA) earnings: FAQ
When is HCA's next earnings date?
We have not yet seen an announcement of the date from HCA Healthcare (HCA). Based on last year's report on Jan 27, 2026, the next report is expected around Jan 26, 2027.
What time does HCA report earnings?
HCA Healthcare usually reports before market open: its latest results release was filed with the SEC at 7:17 am ET on Oct 27, 2026.
When did HCA last report earnings?
HCA Healthcare reported Q3 2026 results on Oct 27, 2026.
Where can I find HCA Healthcare's financial statements?
On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to HCA's filings; this page breaks the latest report down in a Sankey chart.
What was HCA's net income in Q3 2026?
HCA Healthcare reported net income of $1,579M for Q3 2026 (−3.9% year over year), under US GAAP.
Does HCA Healthcare pay dividends?
Yes. In 2025, HCA Healthcare paid $679M in dividends on its common stock, per its 10-K. Earlier years are in the 15-year table above.
How has HCA Healthcare's revenue changed since 2011?
Per its 10-K filings, revenue grew 2.5x: $29,682M in 2011 and $75,600M in 2025. The latest year is the highest in the table. Year-by-year figures are in the table above.
New to earnings reports? Start with how to read an earnings report.
Get it every Monday: who reports this week
Once a week: companies that announced report dates for the week ahead (US and Canada), fresh report breakdowns with charts. Free, no account needed.
More reports: HSIC · Q3 2026 · HUM · Q2 2026 · IDXX · Q3 2026 · ILMN · Q3 2026 · INCY · Q2 2026 · IQV · Q3 2026 · ISRG · Q3 2026 · JNJ · Q3 2026 · LH · Q3 2026 · LLY · Q3 2026 · all reports